Regional amyloid-PET clearance dynamics and anti-Aβ monoclonal antibody therapy: a preliminary real-world study. (PubMed, Alzheimers Dement (Amst)) - Oct 11, 2026 - "Early amyloid clearance following anti-amyloid treatment is regionally heterogeneous and incompletely captured by global PET measures."
Journal • Real-world evidence • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Dementia
|
|
Alma Ghirelli; Ana Maria Samanes Gajate; Andrea Panzacchi; Anna Gilioli; Arturo Chiti; Chiara Tripodi; Edoardo G Spinelli; Elisa Canu; Elisa Sibilla; Fabiola Freri; Federica Agosta; Gino Pepe; Giordano Cecchetti; Giulia Rugarli; Isabella Aurora Lucilla Zamboni; Massimo Filippi; Stefano Pisano; Veronica Castelnovo
|